OTCMKTS:MKKGY Merck KGaA Q4 2024 Earnings Report $31.66 +0.80 (+2.59%) As of 03:53 PM Eastern ProfileEarnings HistoryForecast Merck KGaA EPS ResultsActual EPS$0.54Consensus EPS $0.47Beat/MissBeat by +$0.07One Year Ago EPSN/AMerck KGaA Revenue ResultsActual Revenue$5.78 billionExpected Revenue$5.40 billionBeat/MissBeat by +$379.09 millionYoY Revenue GrowthN/AMerck KGaA Announcement DetailsQuarterQ4 2024Date3/6/2025TimeBefore Market OpensConference Call DateN/AConference Call TimeN/AUpcoming EarningsMerck KGaA's next earnings date is estimated for Thursday, November 12, 2026, based on past reporting schedules. Conference Call ResourcesEarnings HistoryCompany Profile Merck KGaA Earnings HeadlinesDay by Day downgrades Merck KGaA - Depositary Receipt to hold from buySeptember 25 at 7:30 PM | msn.comBio-Techne Shareholders Approve Merck KGaA Acquisition PlanSeptember 23, 2026 | rttnews.comShould You Convert a Traditional IRA to a Roth After 60?Considering a Roth conversion after 60? The upside includes no income limits on conversions, potential tax-free qualified withdrawals, and no lifetime required minimum distributions. The catch: converting triggers ordinary income tax in the year you convert, and the decision cannot be reversed. The right move depends on your income, tax bracket, and retirement timeline.September 28 at 1:00 AM | SmartAsset (Ad)Merck KGaA (OTCMKTS:MKKGY) Given Consensus Recommendation of "Hold" by AnalystsSeptember 22, 2026 | americanbankingnews.comMerck : Computational Chemistry and AI in Chemistry Conference at Headquarters in DarmstadtSeptember 21, 2026 | marketscreener.comMMerck KGaA (MKKGY) Q2 2026 Earnings Call TranscriptAugust 8, 2026 | seekingalpha.comSee More Merck KGaA Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Merck KGaA? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Merck KGaA and other key companies, straight to your email. Email Address About Merck KGaAMerck KGaA (OTCMKTS:MKKGY) is a Germany-based science and technology company headquartered in Darmstadt. Founded in 1668, it is one of the world’s oldest pharmaceutical and chemical businesses. Merck KGaA operates independently from the U.S.-based Merck & Co., Inc., which uses the name MSD in markets outside the United States and Canada. The company operates through three primary business sectors: Life Science, Healthcare and Electronics. Its Life Science business supplies laboratory products, research tools, bioprocessing equipment and services used by academic institutions, pharmaceutical manufacturers and other industrial customers. Healthcare activities include prescription medicines and specialty treatments, with products addressing areas such as oncology, neurology and immunology, as well as fertility and endocrinology. Merck KGaA’s Electronics business develops materials and solutions used in semiconductor manufacturing and display technologies, including specialty chemicals, photoresists and materials for liquid-crystal and OLED applications. The company serves customers in markets around the world through an international research, manufacturing and commercial network. Belén Garijo serves as chair of the company’s executive board and chief executive officer.View Merck KGaA ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Brewing Trouble? Starbucks Spills the Beans on 250 Store ClosuresMarketBeat Week in Review – 09/21 - 09/25Analyst Rating Boosts May Signal More Upside for These 3 Stocks3 Stocks Under the Microscope After Large Insider Sales3 Healthcare Stocks Showing Why the Sector Still Has Momentum2 Cybersecurity Stocks Breaking Out as AI Continues to Be a TailwindFertilizer Prices Keep Climbing: 3 Stocks Still Trading at a Discount Upcoming Earnings Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
